38 Stocks Moving In Wednesday's Mid-Day Session

 

Gainers

  • Vivakor, Inc. VIVK gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.
  • Cosmos Holdings Inc. COSM shares jumped 76.5% to $1.8710 after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net income of $384K.
  • Acutus Medical, Inc. AFIB climbed 31% to $1.0500 after the company announced agreements to fund strategic growth priorities.
  • Nutex Health, Inc. NUTX gained 25.6% to $9.65 after jumping 74% on Tuesday.
  • Tempest Therapeutics, Inc. TPST jumped 20% to $2.84. Tempest reported a $15 million private placement financing.
  • Repligen Corporation RGEN shares climbed 15.8% to $165.01 after reporting upbeat Q1 results.
  • Zentalis Pharmaceuticals, Inc. ZNTL jumped 14.4% to $25.00. Pfizer agreed to invest $25 million in Zentalis Pharmaceuticals via the purchase of 953,834 shares at $26.21 per share.
  • Alkermes plc ALKS gained 14.1% to $30.96 following better-than-expected Q1 results.
  • TradeUP Global Corporation TUGC gained 13.9% to $10.48.
  • Enphase Energy, Inc. ENPH rose 13.4% to $174.50 after the company reported better-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance above analyst estimates.
  • Mattel, Inc. MAT rose 12.1% to $24.77 following a WSJ report suggesting the company is in talks with private-equity firms about a potential sale.
  • Digital World Acquisition Corp. DWAC gained 11.3% to $45.45.
  • Vertiv Holdings Co VRT gained 10.6% to $12.76 following upbeat Q1 results.
  • JinkoSolar Holding Co., Ltd. JKS jumped 10.3% to $55.38.
  • Nordic American Tankers Limited NAT gained 9.6% to $2.7950.
  • Bilibili Inc. BILI surged 9.4% to $22.51.
  • Visa Inc. V rose 8.7% to $218.64 following upbeat quarterly earnings.
  • Microsoft Corporation MSFT rose 4.5% to $282.45 as the company reported better-than-expected results for its third quarter.

 

Losers

  • Molecular Partners AG MOLN shares dipped 37.6% to $8.60. The company’s collaborating partner Amgen for MP0310 (AMG 506) will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.
  • Agile Therapeutics, Inc. AGRX fell 31.4% to $3.07 following effectiveness of 1:40 reverse stock split.
  • NCR Corporation NCR fell 22.9% to $28.78 after the company reported worse-than-expected Q1 EPS and sales results. The company also cut its FY22 EPS and sales guidance.
  • Extreme Networks, Inc. EXTR dipped 15.6% to $9.53 following Q3 results.
  • Immunome, Inc. IMNM dropped 15% to $3.1256.
  • Silence Therapeutics plc SLN fell 14.4% to $12.40.
  • Forge Global Holdings, Inc. FRGE declined 14.1% to $15.86.
  • JE Cleantech Holdings Limited JCSE dropped 13.5% to $14.01.
  • Sono Group N.V. SEV fell 13.5% to $5.11 after the company reported a 10 million share follow-on offering.
  • Evoke Pharma, Inc. EVOK fell 13.1% to $0.7476. Evoke Pharma shares jumped over 118% on Tuesday as the FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
  • F5, Inc. FFIV fell 12.4% to $169.90 after the company reported Q2 earnings results and issued Q3 sales guidance below analyst estimates.
  • Blackboxstocks Inc. BLBX declined 10.6% to $4.30.
  • Hawaiian Holdings, Inc. HA dropped 10.6% to $16.59 following Q1 results.
  • Spotify Technology S.A. SPOT dipped 10.1% to $99.24 after the company reported Q1 financial results.
  • Trinity Industries, Inc. TRN fell 10% to $27.56 following downbeat quarterly results.
  • Diebold Nixdorf, Incorporated DBD dropped 10% to $4.25.
  • Q&K International Group Limited QK shares fell 9.3% to $1.0701 after jumping around 19% on Tuesday.
  • Deutsche Bank Aktiengesellschaft DB shares fell 7.6% to $10.05 following Q1 earnings.
  • Capital One Financial Corporation COF declined 6.6% to $123.53 after the company reported Q1 earnings results.
  • Alphabet Inc. GOOGL fell 4.5% to $2,266.53 following downbeat quarterly earnings.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!